In accordance with previous studies, high frequency of BRCA1 and BRCA2 P or LP variants was present even in the subgroups with the lowest rates, for instance patients with no family history of breast or ovarian cancer and no previous breast cancer had P or LP variants in 16.9% of cases, justifying genetic testing for all patients [30]. The gene discussed is BRCA2; the disease is ovarian cancer.